Breeze Acquisition Corp. II Announces Closing of $15,000,000 Over-Allotment Option
Breeze Acquisition Corp. II (NASDAQ: BREZU) closed the underwriters’ partial exercise of their over-allotment option for 1,500,000 units at $10.00 per unit, bringing its initial public offering to 14,000,000 units.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Breeze Acquisition Corp. II (NASDAQ: BREZU) closed the underwriters’ partial exercise of their over-allotment option for 1,500,000 units at $10.00 per unit, bringing its initial public offering to 14,000,000 units.
Units began trading on May 13, 2026. Each unit includes one ordinary share and one right, with each right converting into one-fifth of a share after an initial business combination.
Positive
- Over-allotment exercise adds 1,500,000 units at $10.00 each
- Total initial public offering reaches 14,000,000 units
- Units listed on Nasdaq Global Market under symbol BREZU
- Ordinary shares and rights expected to trade as BREZ and BREZR
Negative
- Each right converts into one-fifth share, increasing future share count
Key Figures
- Over-allotment option
- $15,000,000
- Underwriters’ partial exercise tied to units offering
- Over-allotment units
- 1,500,000 units
- Additional units sold under over-allotment option
- Unit price
- $10.00 per unit
- Public offering price for each unit
- Total IPO units
- 14,000,000 units
- Aggregate initial public offering size after over-allotment
- Unit share right ratio
- 1/5 of one share
- Each right converts into one-fifth of an ordinary share
- Trading start date
- May 13, 2026
- Units began trading on Nasdaq Global Market
- SEC effectiveness date
- May 12, 2026
- Registration statement declared effective by SEC
Key Terms
over-allotment option financial
initial public offering financial
prospectus regulatory
registration statement regulatory
Securities and Exchange Commission regulatory
business combination financial
Nasdaq Global Market technical
AI-generated analysis. How Rhea-AI works. Not financial advice.
Irving, TX, May 15, 2026 (GLOBE NEWSWIRE) -- Breeze Acquisition Corp. II (NASDAQ: BREZU) (the “Company”) announced today the closing of the underwriters’ partial exercise of the over-allotment option of 1,500,000 units, at a price to the public of
Each unit consists of one ordinary share and one right. Each right entitles the holder to receive one-fifth (1/5) of one ordinary share upon the consummation of an initial business combination. Once the securities comprising the units begin separate trading, the ordinary shares and rights are expected to be traded on the Nasdaq Global Market under the symbols “BREZ” and “BREZR,” respectively.
IB Capital LLC and I-Bankers Securities, Inc. acted as book-running managers of the offering.
ArentFox Schiff LLP acted as counsel to the Company and Allen Overy Shearman Sterling US LLP acted as counsel to the underwriters.
The offering was made only by means of a prospectus. Copies of the prospectus related to this offering may be obtained from IB Capital LLC at 51 Kings Court Street, PH, San Juan, PR 00911.
A registration statement relating to the securities was declared effective by the Securities and Exchange Commission (“SEC”) on May 12, 2026. This press release shall not constitute an offer to sell or the solicitation of an offer to buy any securities, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.
About Breeze Acquisition Corp. II
Breeze Acquisition Corp. II is a blank check company incorporated in the Cayman Islands for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or other similar business combination with one or more businesses or entities. The Company intends to focus its initial search on target businesses with global operations and differentiated technology or capabilities, particularly in healthcare, biotechnology, advanced manufacturing, robotics, artificial intelligence, and related sectors. The net proceeds of the offering will be used to fund such business combination.
Forward-Looking Statements
This press release includes forward-looking statements that involve risks and uncertainties. Forward-looking statements are statements that are not historical facts. Such forward-looking statements are subject to risks and uncertainties, which could cause actual results to differ from the forward-looking statements, including those set forth in the risk factors section of the prospectus used in connection with the Company’s initial public offering filed with the SEC, copies of which are available on the SEC’s website, at www.sec.gov. The Company expressly disclaims any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements contained herein to reflect any change in the Company’s expectations with respect thereto or any change in events, conditions or circumstances on which any statement is based, except as required by law.
Contact:
J. Douglas Ramsey
Breeze Acquisition Corp. II
955 W. John Carpenter Fwy
Suite 100-929
Irving, TX 75039
(888) 273-9001
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.